Statins confer protection against hepatocellular carcinoma in NAFLD patients
Statin use demonstrates a protective effect against hepatocellular carcinoma (HCC), while hypertension confers an increased risk, in patients with nonalcoholic fatty liver disease (NAFLD), a study has found.